Sesión científica Premios Nobel 2012
149
7. Overington, J. P.; Al-‐Lazikani, B. How many drug targets are there?. Nat Rev Drug Discov 5,
993-‐996 (2006).
8. Tyndall, J. D.; R. Sandilya. GPCR agonists and antagonists in the clinic. Med Chem 1, 405-‐421
(2005).
9. Langley, J. N. Observations on the physiological action of extracts of the supra-‐renal bodies. J
Physiol 27, 237-‐256 (1901).
10. Dale, H. H. On some physiological actions of ergot. J Physiol 34, 163-‐206 (1906).
11. Ahlquist, R. P. Adrenergic receptors: a personal and practical view. Perspect Biol Med 17,
119-‐122 (1973).
12. Rall, T. W.;
Sutherland, E. W. Formation of a cyclic adenine ribonucleotide by tissue
particles. J Biol Chem 232, 1065-‐1076. (1958).
13. Walsh, D. A.: Perkins, J. P. et al. An adenosine 3',5'-‐monophosphate-‐dependant protein
kinase from rabbit skeletal muscle. J Biol Chem 243, 3763-‐3765 (1968).
14. Rodbell, M.; Birnbaumer, L. et al. The glucagon-‐sensitive adenyl cyclase system in plasma
membranes of rat liver. V. An obligatory role of guanylnucleotides in glucagon action. J
Biol Chem 246, 1877-‐1882 (1971).
15. Ross, E. M.; Gilman A. G. Resolution of some components of adenylate cyclase necessary for
catalytic activity. J Biol Chem 252, 6966-‐6969 (1977).
16. Lefkowitz, R. J.; Mukherjee, C. et al. Stereospecific (3H)(minus)-‐alprenolol binding sites,
beta-‐adrenergic receptors and adenylate cyclase. Biochem Biophys Res Commun 60, 703-‐
709 (1974).
17. De Lean, A.; Stadel, J. M. et al. A ternary complex model explains the agonist-‐specific
binding properties of the adenylate cyclase-‐coupled beta-‐adrenergic receptor. J Biol Chem
255, 7108-‐7117 (1980).
18. Limbird, L. E.; Gill, D. M. et al. Agonist-‐promoted coupling of the beta-‐adrenergic receptor
with the guanine nucleotide regulatory protein of the adenylate cyclase system. Proc Natl
Acad Sci USA 77, 775-‐779 (1980).
19. Kent, R.A.; DeLean, A; Lefkowitz, R.J. A quantitative-‐analysis of beta-‐adrenergic receptors
interactions: resolution of high and low affinity states of the receptor by computer
modeling of ligand binding data. Mol. Pharm. 17, 14-‐23. (1979)
20. Caron, M. G. ; Lefkowitz, R. J. Solubilization and characterization of the beta-‐adrenergic
receptor binding sites of frog erythrocytes. J Biol Chem 251, 2374-‐2384 (1976).
21. Shorr, R. G.; Lefkowitz, R. J. et al. Purification of the beta-‐adrenergic receptor. Identification
of the hormone binding subunit. J Biol Chem 256, 5820-‐5826 (1981).
22. Benovic, J. L.; Shorr, R. G. et al. The mammalian beta 2-‐adrenergic receptor: purification and
characterization. Biochemistry 23(20): 4510-‐4518 (1984).
23. Lefkowitz, R. J. Seven transmembrane receptors: a brief personal retrospective. Biochim
Biophys Acta 1768 748-‐755 (2007).
24. Lefkowitz, R. J. Historical review: a brief history and personal retrospective of seven-‐
transmembrane receptors." Trends Pharmacol Sci 25(8): 413-‐422 (2004).
25. Dixon, R. A.; B. K. Kobilka, et al. Cloning of the gene and cDNA for mammalian beta-‐
adrenergic receptor and homology with rhodopsin. Nature 321, 75-‐79 (1986).
26. Benovic, J. L.; F. Mayor, Jr., et al. Light-‐dependent phosphorylation of rhodopsin by beta-‐
adrenergic receptor kinase. Nature 321, 869-‐872 (1986).
27. Kubo, T.; Fukuda, K. et al. Cloning, sequencing and expression of complementary DNA
encoding the muscarinic acetylcholine receptor. Nature 323, 411-‐416 (1986).
